Adjuvant Hormonotherapy and Cardiovascular Risk in Post-Menopausal Women with Breast Cancer: A Large Population-Based Cohort Study

Adjuvant Hormonotherapy and Cardiovascular Risk in Post-Menopausal Women with Breast Cancer: A Large Population-Based Cohort Study

Background: Whether aromatase inhibitors (AIs) increase the risk of cardiovascular (CV) events, compared to tamoxifen, in women with breast cancer is still debated. We evaluated the association between AI and CV outcomes in a large population-based cohort of breast cancer women. Methods: By using he...

Full description

Bibliographic Details
Main Authors: Matteo Franchi, Roberta Tritto, Luigi Tarantini, Alessandro Navazio, Giovanni Corrao
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
breast cancer
aromatase inhibitors
cardiovascular risk
heart failure
clinical practice
Online Access:https://www.mdpi.com/2072-6694/13/9/2254

Similar Items

Similar Items